These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 10860939)

  • 1. Cellular response to a glutathione S-transferase P1-1 activated prodrug.
    Rosario LA; O'Brien ML; Henderson CJ; Wolf CR; Tew KD
    Mol Pharmacol; 2000 Jul; 58(1):167-74. PubMed ID: 10860939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor efficacy and bone marrow-sparing properties of TER286, a cytotoxin activated by glutathione S-transferase.
    Morgan AS; Sanderson PE; Borch RF; Tew KD; Niitsu Y; Takayama T; Von Hoff DD; Izbicka E; Mangold G; Paul C; Broberg U; Mannervik B; Henner WD; Kauvar LM
    Cancer Res; 1998 Jun; 58(12):2568-75. PubMed ID: 9635580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a glutathione S-transferase pi-activated prodrug in platinum-resistant ovarian cancer cells.
    Townsend DM; Shen H; Staros AL; Gaté L; Tew KD
    Mol Cancer Ther; 2002 Oct; 1(12):1089-95. PubMed ID: 12481432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacologic or genetic manipulation of glutathione S-transferase P1-1 (GSTpi) influences cell proliferation pathways.
    Ruscoe JE; Rosario LA; Wang T; Gaté L; Arifoglu P; Wolf CR; Henderson CJ; Ronai Z; Tew KD
    J Pharmacol Exp Ther; 2001 Jul; 298(1):339-45. PubMed ID: 11408560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester.
    Nakajima T; Takayama T; Miyanishi K; Nobuoka A; Hayashi T; Abe T; Kato J; Sakon K; Naniwa Y; Tanabe H; Niitsu Y
    J Pharmacol Exp Ther; 2003 Sep; 306(3):861-9. PubMed ID: 12805482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of latent alkylating agents activated by glutathione S-transferase.
    Satyam A; Hocker MD; Kane-Maguire KA; Morgan AS; Villar HO; Lyttle MH
    J Med Chem; 1996 Apr; 39(8):1736-47. PubMed ID: 8648613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione peptidomimetic drug modulator of multidrug resistance-associated protein.
    O'Brien ML; Vulevic B; Freer S; Boyd J; Shen H; Tew KD
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1348-55. PubMed ID: 10565860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of TER286 against human tumor colony-forming units.
    Izbicka E; Lawrence R; Cerna C; Von Hoff DD; Sanderson PE
    Anticancer Drugs; 1997 Apr; 8(4):345-8. PubMed ID: 9180387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell responses to a novel glutathione S-transferase-activated nitric oxide-releasing prodrug.
    Findlay VJ; Townsend DM; Saavedra JE; Buzard GS; Citro ML; Keefer LK; Ji X; Tew KD
    Mol Pharmacol; 2004 May; 65(5):1070-9. PubMed ID: 15102935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione-S-transferase activates novel alkylating agents.
    Lyttle MH; Satyam A; Hocker MD; Bauer KE; Caldwell CG; Hui HC; Morgan AS; Mergia A; Kauvar LM
    J Med Chem; 1994 May; 37(10):1501-7. PubMed ID: 8182709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detoxification of 1-chloro-2,4-dinitrobenzene in MCF7 breast cancer cells expressing glutathione S-transferase P1-1 and/or multidrug resistance protein 1.
    Diah SK; Smitherman PK; Townsend AJ; Morrow CS
    Toxicol Appl Pharmacol; 1999 Jun; 157(2):85-93. PubMed ID: 10366541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brostallicin, a novel anticancer agent whose activity is enhanced upon binding to glutathione.
    Geroni C; Marchini S; Cozzi P; Galliera E; Ragg E; Colombo T; Battaglia R; Howard M; D'Incalci M; Broggini M
    Cancer Res; 2002 Apr; 62(8):2332-6. PubMed ID: 11956092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of coordinate overexpression of glutathione phase II detoxification gene products on drug resistance.
    O'Brien M; Kruh GD; Tew KD
    J Pharmacol Exp Ther; 2000 Aug; 294(2):480-7. PubMed ID: 10900222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of glutathione S-transferase P1, P-glycoprotein and multidrug resistance-associated protein 1 in acquired doxorubicin resistance.
    Harbottle A; Daly AK; Atherton K; Campbell FC
    Int J Cancer; 2001 Jun; 92(6):777-83. PubMed ID: 11351295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-immolative nitrogen mustard prodrugs for suicide gene therapy.
    Niculescu-Duvaz D; Niculescu-Duvaz I; Friedlos F; Martin J; Spooner R; Davies L; Marais R; Springer CJ
    J Med Chem; 1998 Dec; 41(26):5297-309. PubMed ID: 9857097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in glutathione and glutathione-related enzymes in a multidrug-resistant small cell lung cancer cell line.
    Cole SP; Downes HF; Mirski SE; Clements DJ
    Mol Pharmacol; 1990 Feb; 37(2):192-7. PubMed ID: 1968221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
    Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
    Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective inhibition of MCF-7(piGST) breast tumors using glutathione transferase-derived 2-methylene-cycloalkenones.
    Joseph E; Ganem B; Eiseman JL; Creighton DJ
    J Med Chem; 2005 Oct; 48(21):6549-52. PubMed ID: 16220971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine cytotoxicity and DNA adduct formation in human prostate by glutathione S-transferase P1.
    Nelson CP; Kidd LC; Sauvageot J; Isaacs WB; De Marzo AM; Groopman JD; Nelson WG; Kensler TW
    Cancer Res; 2001 Jan; 61(1):103-9. PubMed ID: 11196146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-associated enzymes in the human cell lines of the National Cancer Institute Drug Screening Program.
    Tew KD; Monks A; Barone L; Rosser D; Akerman G; Montali JA; Wheatley JB; Schmidt DE
    Mol Pharmacol; 1996 Jul; 50(1):149-59. PubMed ID: 8700107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.